3Takemoto Y;Hata T;Kamina K.Leukemia is developing after treatment for thyroid cancer in a patient with Werner's sydrome:Molec-ular and cytogentic studies,1995.
5[1]Zutter M M, Durnam D M, Hackman R C, et al. Secondary T-cell lymphoproliferation after marrow transplantation . Am J Clin Pathol,1990,94:714-721.
6[2]Witherspoon R P,Fisher L D,Schoch G,et al.Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia.N Engl J Med,1989,321:784-789.
7[3]Deeg H J,Socie G.Malignancies after hematopoietic stem cell transplantation:many questions,some answers.Blood ,1998,91:1833-1844.
8[4]Hale G, Waldmann H. Risks of developing Epstein-Barr virus-related lymphoproliferative disorders after T-cell-depleted marrow transplants. Blood,1998,91:3097-3083.
9[5]Penn I. The changing pattern of `posttransplant malignancies.Transplant Proc,1991,23:1101-1103.
10[6]Gorp J V, Doornewaard H, Verdonck L. Posttransplant T cell lymphoma :report of three cases and a review of the literature.Cancer,1994,73:3064-3072.
3Creutzig U, Zimmemlann M, Dworzak M, et al. Favourable outcome of patients with childhood acute promyelocytic leukaemia after treatment with reduced cumulative anthracycline doses. Br J Haematol, 2010 ; 149 ( 3 ) :399 - 409.
4Mathews V, George B. Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: durable remissions with minimal toxicity. Blood, 2006 ; 107 ( 7 ) : 2627 - 2632.
5Warren S, Gat es O. Multiple primary malignant tumours : A survey of the literature and statistical study. Am J Cancer, 1982; 152(51):1358 -1403.
6Matsuzoe D, Hideshima T, O hsh ima K, et al. Discrimination of double primary lung cancer from intrapu lmonary metastasis by p53 genemutation. Br J Cancer, 1999; 79 (9/10) :1549 - 1552.
7Melike P, Jonathan L, Nalin G, characteristics of glomas: 19852005 et al. Clinicopathological and papillary craniopharyn- University of California, San Francisco experience Neurosurg, 2010; 67(5) :1341 - 1349.
8Niki K, Simon C, Christopher B, et al. Cranionpharyngiomas. Endocrine Rev,2006 ;27 (4) :371 - 397.
9Koh Y, Kim I, Bae JY, et al. Prognosis of secondary acute myeloid leukemia is affected by the type of the preceding hematologic disorders and the presence of trisomy 8[J]. Jpn J Clin Oncol, 2010, 40(11): 1037-1045.
10Cowell IG, Austin CA. Mechanism of generation of therapy related leukemia in responseto anti-topoisomeraseⅡ agents[J]. Int J Environ Res Public Health, 2012, 9(6): 2075-2091.
